{"CONCEPT_ID":[1114220],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["naloxone"],"NUM_PERSONS":[6],"PERCENT_PERSONS":["0.0051"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"MALE","MIN_VALUE":24,"P10_VALUE":24,"P25_VALUE":24,"MEDIAN_VALUE":36,"P75_VALUE":53,"P90_VALUE":65,"MAX_VALUE":65},{"CATEGORY":"FEMALE","MIN_VALUE":23,"P10_VALUE":23,"P25_VALUE":23,"MEDIAN_VALUE":23,"P75_VALUE":23,"P90_VALUE":23,"MAX_VALUE":23}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"30-39","SERIES_NAME":"MALE","X_CALENDAR_YEAR":2014,"Y_PREVALENCE_1000PP":16.6667},{"TRELLIS_NAME":"20-29","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2014,"Y_PREVALENCE_1000PP":13.6986},{"TRELLIS_NAME":"20-29","SERIES_NAME":"MALE","X_CALENDAR_YEAR":2014,"Y_PREVALENCE_1000PP":13.5135},{"TRELLIS_NAME":"20-29","SERIES_NAME":"MALE","X_CALENDAR_YEAR":2015,"Y_PREVALENCE_1000PP":13.8889},{"TRELLIS_NAME":"60-69","SERIES_NAME":"MALE","X_CALENDAR_YEAR":2015,"Y_PREVALENCE_1000PP":20},{"TRELLIS_NAME":"50-59","SERIES_NAME":"MALE","X_CALENDAR_YEAR":2016,"Y_PREVALENCE_1000PP":16.129}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":201403,"Y_PREVALENCE_1000PP":1.9646},{"X_CALENDAR_MONTH":201604,"Y_PREVALENCE_1000PP":0.9766},{"X_CALENDAR_MONTH":201404,"Y_PREVALENCE_1000PP":0.9823},{"X_CALENDAR_MONTH":201502,"Y_PREVALENCE_1000PP":0.9785},{"X_CALENDAR_MONTH":201501,"Y_PREVALENCE_1000PP":0.9785}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":142,"P10_VALUE":142,"P25_VALUE":1728,"MEDIAN_VALUE":1996,"P75_VALUE":2246,"P90_VALUE":2473,"MAX_VALUE":2473}]}
